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Aims High-density lipoprotein (HDL) is known for its cardioprotective properties independent from its cholesterol trans-
port activity. These properties are mediated by activation of kinases such as protein kinase C (PKC). Connexin43
(Cx43) is a gap junction protein present in ventricular cardiomyocytes. PKC-dependent phosphorylation modifies
Cx43 gap junction channel properties and is involved in cardioprotection. We hypothesized that cardioprotective
properties of HDL may be mediated in part by affecting Cx43 gap junction channels.
Methods
and results
Neonatal rat cardiomyocytes were treated with HDL and Cx43 phosphorylation was evaluated by western blotting
and immunofluorescence. We found that HDL promoted phosphorylation of Cx43 with a maximal induction at
5 min, which was inhibited by pre-treatment with various PKC inhibitors. Sphingosine-1-phosphate (S1P), a com-
ponent of HDL, induced effects that were similar to those of HDL. These compounds significantly reduced diffusion
of fluorescent dye among cardiomyocytes (50%) which could be prevented by PKC inhibition. As observed during
optical recordings of transmembrane voltage, HDL and S1P depressed impulse conduction only minimally (,5%).
Moreover, 5 min of HDL and S1P treatment at the onset of reperfusion significantly reduced infarct size (50%)
in response to 30 min ischaemia in ex vivo experiments.
Conclusion Short-term treatment with HDL or S1P induces phosphorylation of Cx43 by a PKC-dependent pathway.
HDL-induced phosphorylation of Cx43 reduced the diffusion of large tracer molecules between cells, whereas
impulse conduction was maintained. Moreover, 5 min treatment with HDL confers cardioprotection against ischae-
mia/reperfusion injury. These results link Cx43 for the first time to the short-term cardioprotective effects of HDL.
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1. Introduction
High-density lipoprotein cholesterol (HDL-C) level correlates inver-
sely with the risk of cardiovascular diseases.1 The anti-atherogenic
effects of HDL have been linked to its capacity to transfer excess
cholesterol from peripheral tissues to the liver in a process known
as reverse cholesterol transport. More recently, HDL has also been
shown to exert anti-inflammatory, antioxidative, anti-apoptotic and
vasodilatory functions involving non-cholesterol-dependent actions
on endothelial and smooth muscle cells. These properties are
mediated by several cellular signaling cascades including PKC,
mitogen-activated protein kinase [MAPK: p38-MAPK, extracellular
signal-regulated kinase (ERK)1/2 and c-Jun kinase (JNK)] and
phosphatidyl-inositol-3-kinase (PI3K/Akt).2 However, little infor-
mation is available about protective effects of HDL on cardiomyocyte
function.
Action potential propagation in the hearts depends on electrical
coupling of cardiomyocytes by gap junctions (GJ).3 Moreover, GJ
permit intercellular spread of biologically active compounds that
include substances deciding over cell survival vs. cell death in
various types of cells.4 GJ channels are formed by members of a
family of transmembrane proteins called connexins (Cx). The predo-
minant connexin between ventricular cardiomyocytes is Connexin43
(Cx43). It is typically located at the intercalated disk in the intact ven-
tricular myocardium, but can move to the lateral plasma membranes
in response to ischaemia. These changes are accompanied by changes
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in Cx43 phosphorylation. Phosphorylation of Cx43 by different
protein kinases, such as PKC or MAPK, has been implicated in con-
nexin expression, trafficking, assembly, degradation and GJ channel
gating.5
There is increasing evidence that regulation of Cx43 plays an
important role in cardioprotection. This is evident from studies
aimed at understanding the phenomenon of ischemic preconditioning
(IPC), where brief periods of ischaemia and reperfusion in intact
hearts can minimize damage from a subsequent prolonged period
of ischaemia. The beneficial effects of IPC include a reduction of
infarct size and a suppression of ischaemia-associated arrhythmias.6
Cx43 is known to be essential for the beneficial effects of IPC as
shown by the absence of preconditioning effects in heterozygous
Cx43 null mice.7 Whether Cx43 may also be involved in cardiopro-
tection conferred by compounds applied during early reperfusion
however remains largely unknown.
In the present study, we investigated whether the protective effects
of HDL involve cardiac GJ. We show for the first time that HDL
induces the phosphorylation of Cx43 in neonatal rat cardiomyocytes
by a PKC-dependent mechanism. HDL induced a large reduction
(50%) in the spread of a large tracer, whereas it had minimal
effects (,5%) on impulse propagation. Moreover, 5 min of HDL
treatment at the onset of reperfusion limited infarct size induced by
an ischaemia/reperfusion protocol ex vivo. These effects involved the
Sphingosine-1-phosphate (S1P) component of HDL. Our findings
suggest that HDL might exert direct protective effects on cardiomyo-
cyte function by inducing PKC-mediated phosphorylation of Cx43,
which, in turn, result in limitation of the diffusion of damaging mol-
ecules through GJ channels while cardiac conduction is preserved.
2. Methods
2.1 HDL preparation
High density lipoprotein (HDL) (d ¼ 1.063–1.21 g/mL) was isolated by
cumulative flotation ultracentrifugation from a plasma pool provided by
healthy volunteers as describe previously.8 HDL was subsequently dia-
lyzed against PBS containing EDTA (1 mmol/L) and stored at 48C. Exper-
iments conformed to Geneva University ethics review board (number
07–037), and are in accordance with the Declaration of Helsinki.
2.2 Cell culture
Isolation of neonatal ventricular cardiomyocytes was performed on 1 to
2-day-old Wistar rats euthanized by decapitation. Cells were isolated by
digestion with trypsin-EDTA and collagenase. Cultures were used at the
third day, after 20–24 h serum starvation.9 Briefly, after digestion, the
cells were pooled in Dulbecco’s modified Eagle’s medium (DMEM, Invitro-
gen, Groningen, the Netherlands) supplemented with 10% fetal calf serum
(FCS, Biochrom AG, Berlin, Germany), penicillin (100 U/mL) and strepto-
mycin (10 mg/mL) and seeded in 150 cm2 flasks to allow selective
adhesion of cardiac fibroblasts. After 1 h, cardiomyocytes were decanted
from the plates and seeded in petri dishes. For all experiments described
herein, cells were used on the third day of culture after having undergone
serum starvation for 20–24 h in DMEM without FCS. Experiments con-
formed to the Guide for the Care and Use of Laboratory Animals published
by the US National Institutes of Health (NIH Publication No. 85–23,
revised 1966) and were approved by the cantonal veterinary authorities
(number 1012/3134/0-R).
Neonatal rat ventricular myocytes were treated with HDL at the con-
centration of 400 mg/mL as described in previous reports from our lab-
oratory10 and incubation times varied from 5 to 60 min. Pre-treatments
with kinase inhibitors were performed 30 min before HDL incubation
by using inhibitors of PKC (Chelerythrin 5 mmol/L (Chel.), Sigma-Aldrich;
Staurosporine 1 mmol/L (STS); Bisindoylemaleinide I 2 mmol/L (BIMI), Cal-
biochem), p38-MAPK (SB203580 10 mmol/L, Calbiochem), JNK
(SP600125 10 mmol/L, Calbiochem), ERK (UO126 5 mmol/L, Calbio-
chem), or Akt (LY294002 10 mmol/L, Calbiochem). Neonatal cardiomyo-
cytes were also treated with S1P (Sigma-Aldrich) at the concentration of
0.1 mmol/L during 5 min.
2.3 Protein extraction and western blotting
Proteins were extracted from neonatal rat ventricular myocytes exposed
to the various experimental protocols in modified RIPA buffer (Tris–HCl
pH 8.0 20 mmol/L, NaCl 1 mol/L, NP-40 1%, NaF 50 mmol/L,
Na-orthovanadate 10 mmol/L, PMSF 1 mmol/L, EDTA 5 mmol/L, SDS
0.25%, Na-deoxycholate 1%, cocktail of protease inhibitors) as previously
described.11 Western blotting was performed using antibodies against all
Cx43 species irrespectively of the phosphorylation sites (BD Transduc-
tion Laboratories), Phospho-Cx43 (Ser368) (Cell Signaling), the N-
terminal part of Cx43 (Fred Hutchinson Cancer Research Center),
Phospho-p38-MAPK (Cell Signaling), Phospho-ERK1/2 (Cell Signaling),
Phospho-Akt (Cell Signaling), Phospho c-jun (Santa Cruz Biotechnology),
and GAPDH (Chemicon).
2.4 Immunofluorescence
Neonatal rat ventricular myocytes were cultured on coverslips for 3 days,
treated for 5 min with HDL (400 mg/mL) and then fixed for 5 min in
methanol at 2208C. Cells were immunolabelled with phospho-Cx43
(Ser368) antibodies or N-term Cx43 antibodies. Cells were counter-
stained with Evans blue and nuclei were stained with
4′,6-diamidino-2-phenylindole. Staining was examined with a TMD300
microscope (Nikon AG, Ku¨snacht, Switzerland) equipped with a high-
sensitivity Visicam camera (Visitron Systems GmbH, Puchheim,
Germany) connected to a personal computer running Metafluor 4.01 soft-
ware (Universal Imaging, Sunnyvale, CA, USA).
2.5 Dye coupling
For the analysis of dye transfer, one neonatal rat ventricular myocyte
within a cluster of cardiomyocytes was impaled with a thin tip microelec-
trode filled with 4% Lucifer yellow dissolved in 150 mmol/L LiCl buffered
to pH 7.2. The tracer was allowed to fill the cells by simple diffusion for
3 min. At the end of the injection period, the electrode was carefully
removed and all Lucifer Yellow-positive cells, irrespective of their absol-
ute level of specific fluorescence, were counted immediately using an
inverted TMD-300 microscope (Nikon, Egg, Switzerland) equipped with
a x40 phase 3 dark medium objective with a numerical aperture of 0.7
(Carl Zeiss) and appropriate filters.12 –14 Neonatal cardiac cells were
treated with HDL (400 mg/mL) or S1P (0.1 mmol/L) for 5 min before
dye injection. Chelerythrin pre-treatment (5 mmol/L) was performed
30 min before HDL incubation. To estimate the reversibility of HDL or
S1P treatments, cells were rinsed during 10 min with PBS before dye
injection. Microinjections have been also performed in the presence of
12-O-tetradecanoylphorbol-13-acetate (TPA, 100 nM, 15 min), a PKC
activator.
2.6 Optical recording of electrical activity
Patterned growth neonatal rat ventricular myocytes preparations (strands
measuring 4.2 × 0.6 mm) were obtained using photolithographic tech-
niques as described previously.15 Strands were kept in culture for
3 days (serum starved for the last 24 h) before being stained for 5 min
with the voltage sensitive dye di-8-ANEPPS (135 mmol/L; Biotium). For
optical measurements, preparations were mounted in a temperature con-
trolled superfusion chamber on top of an inverted microscope equipped
for epifluorescence (Zeiss 135 M) where they were superfused
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continuously at 368C with Hanks’ balanced salt solution (HBSS, Sigma)
containing (mmol/L) NaCl 137, KCl 5.4, CaCl2 1.3, MgSO4 0.8,
NaHCO3 4.2, KH2PO4 0.5, NaH2PO4 0.3, and HEPES 10. The fluor-
escence emitted from the voltage sensitive dye was recorded with high
spatio-temporal resolution using a fibre optic recording system described
in detail before.16 All recordings were done at 20× magnification (Fluar
20×, 0.75 N.A., Zeiss, Switzerland) resulting in a spatial resolution of
50 mm. Cardiomyocyte strands were pre-stimulated for 10 s at 2 Hz
with an electrode placed next to the individual strands (1 mm) to
obtain steady-state conduction conditions at the time of measurement.
The amplitudes of optically recorded action potential upstrokes were
scaled to 100% (%APA) and maximal upstroke velocities (dV/dtmax)
were calculated from %APA values and are given in %APA/ms. Under
the assumption that action potential amplitudes correspond to 100 mV,
%APA/ms translates into V/s. Experiments were performed in triplicate
at a given site [control, exposure to HDL (400 mg/mL) or 0.1 mmol/L
S1P, washout].
2.7 Ex vivo Langendorff perfusion
Animal experimentation conformed to the Guide for the Care and Use of
Laboratory Animals published by the US National Institutes of Health
(NIH Publication No. 85–23, revised 1966) and was approved by the can-
tonal veterinary authorities (number 1045/3272/0-R). Sprague-Dawley
rats were anaesthetized by one intraperitoneal injection of thiopental-
natrium (150 mg/kg), and the adequacy of anaesthesia was confirmed
with the absence of pedal reflex. The hearts (n ¼ 5–6/group) were iso-
lated and perfused in a modified Langendorff system under constant
pressure (70 mmHg) with gassed (94% O2–6% CO2) Krebs–Heinseleit
buffer solution (NaCl 118 mM, KCl 4.7 mM, MgSO4 1.19 mM, KH2PO4
1.2 mM, CaCl2 1.36 mM, NaHCO3 25 mM, Glucose 11 mM) at 378C, as
described previously.17 An intraventricular balloon was introduced in
the left ventricule and the left ventricular end-diastole pressure
(LVEDP) was fixed to 6 mmHg. The hearts were stabilized for 30 min
and subsequently exposed to 30 min of no-flow global ischaemia followed
by 60 min of reperfusion. HDL (800 mg/mL) or S1P (0.4 mmol/L) has been
added to the perfusion during the first 5 min of reperfusion. The left ven-
tricular developed pressure (LVDP) and the heart rate (HR) were con-
tinuously monitored during the experiments. The rate-pressure product
was calculated as LVDP×HR. At the end of the reperfusion, the heart
was immediately frozen. Frozen hearts were cut into six to seven slices
and incubated with triphenyltetrazolium chloride (TTC) to stain viable
myocardium. The contrast between TTC-stained and unstained areas
was enhanced by immersion in 10% formalin for 1 day. Total myocardial
and infarcted areas were measured from computed images using NIH
Image software. Infarct areas were normalized to total left ventricular
areas and averaged for individual hearts.
2.8 Statistical analysis
The data are presented as mean+ SEM. Independent experiments were
compared by Student’s t-test. Differences indicated by an asterisk or a
number sign were considered statistically significant at P, 0.05.
3. Results
3.1 Effects of HDL and S1P on Cx43
expression and phosphorylation
The effects of HDL treatment on Cx43 expression and phosphorylation
were determined by western blotting with three different antibodies.
One antibody recognizing all Cx43 isoforms (Figure 1A—upper panel
and Figure 1B), a second antibody directed against the phosphorylated
Serine 368 (Ser368) of Cx43 (Figure 1A—lower panel and Figure 2A)
and a third antibody recognizing the N-terminal part of Cx43 allowing
for reliable quantification of the total amount of Cx43 (Figure 2B). We
found that treatment with 400 mg/mL HDL induced an increase in
Cx43 phosphorylation with the maximal effect after 5 min of incubation
(Figure 1A). Pre-treatment of the cells with inhibitors against p38-MAPK
(SB203580), JNK (SP600125), ERK1/2 (UO126), or PI3K/Akt
(LY294002) pathways did not affect the HDL effect on Cx43 phos-
phorylation (Figure 1B). The efficiency of these inhibitors was verified
by western blotting with antibodies against phospho-p38-MAPK,
phospho-c-jun, phospho-ERK1/2, and phospho-Akt. As shown in Sup-
plementary material online, Figure S1, the phosphorylation of these
targets by HDL was reversed by pre-treatment with the different inhibi-
tors. Pre-incubation of neonatal rat ventricular cells for 30 min with
different PKC inhibitors (chelerythrin: Chel., Staurosporine: STS or
Bisindoylemaleinide I: BIMI) blocked HDL-induced phosphorylation of
Cx43 (Figures 1B and 2A). Treatment with HDL and PKC inhibitors
did however not modify the total amount of Cx43 (Figure 2B). In
addition, treatment of neonatal cardiomyocytes with 0.1 mmol/L S1P
induced comparable level of Cx43 phosphorylation as HDL treatment
(Figures 1B and 2A), without affecting the total amount of Cx43
(Figure 2B). Pre-treatment with the different PKC inhibitors also
blocked the effect of S1P on Cx43 phosphorylation (Figures 1B and 2A).
Immunostaining with the different antibodies showed that the Cx43
isoforms are primarily localized at the plasma membrane between
cardiomyocytes (Figure 3A). Moreover, we observed increased staining
with the Ser368 antibody after HDL treatment, which confirmed the
results obtained by western blotting.
3.2 Effects of HDL on gap junctional
communication
Microinjection of the fluorescent tracer LY revealed that the dye dif-
fused to 16+2 cardiomyocytes (control, n ¼ 38, Figure 3C) within
3 min. HDL treatment induced a significant decrease in LY diffusion
(6+1cells, n ¼ 42, P, 0.01) and pre-treatment with
chelerythrin blocked the HDL effects on LY diffusion (14+2 cells,
n ¼ 11, P, 0.01 vs. HDL, Figure 3C). Similarly, S1P treatment
also reduced spread of the fluorescent tracer (9+1 cells, n ¼ 29,
P, 0.01 vs. control, Figure 3C). Moreover, washout of HDL and
S1P restored LY diffusion to values close to control (16+3 cells,
n ¼ 11 and 12+3 cells, n ¼ 9, respectively, Figure 3C). In agreement,
incubation of neonatal cardiomyocytes with the PKC activator TPA
significantly reduced dye coupling between the cells (3+1 cells,
n ¼ 16, P, 0.01 vs. control, Figure 3C).
In contrast to the substantial reduction in LY diffusion, HDL treat-
ment caused an only small and reversible reduction in conduction vel-
ocities (Figure 4A, left panel; control: 327+ 4 mm/s, n ¼ 65;
HDL treatment: 310+3 mm/s, n ¼ 65, P, 0.05; washout: 325+
3 mm/s, n ¼ 46). In parallel, HDL treatment caused a reversible
small reduction in maximal upstroke velocities (Figure 4A, right
panel; control: 79.8+ 0.2 %APA/ms; HDL treatment: 78.0+ 0.2
%APA/ms, n ¼ 65, P, 0.05; washout: 80.0+0.2 %APA/ms, n ¼ 65).
As shown in Figure 4B, the effects on conduction velocity were
maximal after 5 min of HDL incubation. Moreover, S1P treatment
induced also small but significant reductions in conduction velocities
(control: 326+3 mm/s; S1P: 314+3 mm/s, P, 0.05, n ¼ 57,
Figure 4C, left panel) and maximal action potential upstroke velocities
(control: 80.7+ 0.2 %APA/ms; S1P:79.8+0.2 %APA/ms, P, 0.05,
n ¼ 57, Figure 4C, right panel) similar to that observed during HDL
exposure.
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3.3 Effect of HDL on ischaemia/
reperfusion-induced cell death
The therapeutic potential of short-term (5 min) treatment of HDL or
S1P was determined in isolated heart perfusion experiments ex vivo in
which hearts were submitted to 30 min of no-flow global ischaemia
followed by 60 min of reperfusion (Figure 5A). During the stabilization
period, the LVEDP was set 6 mmHg for each heart [control: 6+1
(n ¼ 5); HDL: 6+1 (n ¼ 6); S1P: 7+1 mmHg (n ¼ 6)]. The LVDP
and the HR were monitored and the rate-pressure product
(LVDP × HR) was calculated. At the end of the stabilization period,
LVDP × HR was similar between the three experimental groups
(control: 28+2; HDL: 29+ 1; S1P: 27+ 2 mmHg × 103/min, ns).
HDL or S1P was added to the perfusion buffer only during the first
5 min of the reperfusion (Figure 5A). Under control conditions, we
observed cell death in 23+ 3% of the total ventricle (Figure 5B).
This infarct size was significantly reduced by 5 min of HDL or S1P
treatment at the onset of reperfusion. Indeed, cell death was only
observed in 13+2% of HDL treated and in 11+2% of S1P
treated ventricle, (P, 0.05 vs. control, Figure 5B).
4. Discussion
Connexins are highly regulated membrane proteins with a C-terminal
domain that plays key regulatory roles and provides sites of protein–
protein interactions.18 Cx43 is a phosphoprotein, and its phosphoryl-
ation state influences gap junctional intercellular communication
(GJIC).5 In this study, we show that HDL treatment induced an
increase in Cx43 phosphorylation. This phosphorylation is maximal
after 5 min of incubation with HDL and involves the Serine residue
at position 368 in the C-terminal tail of Cx43. Pre-incubation of neo-
natal cardiomyocytes with inhibitors of MAP kinases or Akt pathways
had no effect on HDL-induced phosphorylation of Cx43, whereas
three different PKC inhibitors blocked this effect. Although the con-
stituents of the HDL particle that mediate the diverse biological
Figure 1 Cx43 phosphorylation in neonatal rat cardiomyocytes after treatment with HDL or S1P. (A) Quantification of Cx43 by western blot
showed that HDL (400 mg/mL) induced a global transient increase in Cx43 phosphorylation (upper panel), and more particularly phosphorylation
of Serine368 (lower panel). Figure shows representative western blots for Cx43 in the absence of HDL or after 5, 15, 30, and 60 min of HDL incu-
bation. Data of six independent experiments are expressed in ratio of phosphorylation status of Cx43 in control conditions. (B) Quantification of
phospho-Cx43 after incubation with kinase inhibitors for 30 min and HDL or S1P for 5 min. Inhibition of PKC with Chelerythrin (Chel.) blocked
the phosphorylation of Cx43 induced by HDL, whereas the inhibition of p38-MAPK, JNK, ERK1/2, or Akt, respectively by SB203580, SP600125,
UO126, or LY294002 did not affect HDL-induced Cx43 phosphorylation. Moreover, treatment with S1P significantly increased Cx43 phosphorylation,
an effect blocked by pre-incubation with Chelerythrin. Data of 4–11 independent experiments were normalized to the phosphorylation state of Cx43
measured under control conditions.
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effects remain to be identified, several recent studies have linked the
S1P component to the cardioprotective properties of HDL.19 We
observe here that S1P induced comparable levels of Cx43 phos-
phorylation as HDL treatment in neonatal rat cardiomyocytes. More-
over, S1P-induced phosphorylation of Cx43 was also blocked by the
inhibition of PKC, suggesting a common pathway for HDL and S1P.
These results demonstrate for the first time that HDL and its com-
ponent S1P induce phosphorylation of Cx43 by a PKC-dependent
mechanism.
Cx43 phosphorylation regulates many aspects of the connexin life
cycle, including expression, trafficking, assembly, gating, and degra-
dation.5 Moreover, the effects of Cx43 phosphorylation on GJIC
are strongly dependent on the phospho-amino acid involved. Thus,
phosphorylation of Ser368 in Cx43 by PKC has been shown to
inhibit GJIC.20 In this study, we show that HDL limits the spread of
large tracer molecules between neonatal rat cardiomyocytes by
50%. The effects of HDL on GJIC might be due to an action of
HDL particles on the cholesterol content of cardiomyocyte plasma
membranes. Indeed, changing the cholesterol content of plasma mem-
branes is known to affect GJIC in neonatal cardiomyocytes.21
However, this contribution will be minor compared with the effect
of HDL on Cx43 phosphorylation, because S1P that is incapable of
transporting cholesterol induces a similar effect as HDL on GJIC.
Moreover, HDL- and S1P-induced reduction in GJIC can be prevented
by inhibition of PKC, and the effects are reversible after the washout
of the two compounds. Thus, HDL and S1P reversibly reduce GJ dye
permeability between neonatal rat cardiomyocytes in a
PKC-dependent manner. As published previously, a reduction in GJ
permeability limits the spread of mediators implicated in death
pathway during ischaemia and reperfusion.22 Consequently, limitation
of GJIC by HDL may limit the passage of death signals between car-
diomyocytes, thus conferring cardioprotection in limiting infarct
size. S1P enhanced survival of neonatal cardiomyocytes under
hypoxic conditions, and that these anti-apoptotic properties of S1P
are mediated by a PKC-dependent mechanism.23 All together, these
studies and our results suggest that limitation of Cx43-mediated
Figure 2 PKC-dependent effects of HDL and S1P on Cx43 phosphorylation . (A) Quantification of phospho-Cx43 on Serine368 in cardiomyocytes
treated with HDL, S1P, Chelerythrin, Staurosporine, or Bisindoylemaleinide I. HDL and S1P treatments induced phosphorylation of Cx43 on
Serine368. Moreover, PKC inhibition by Chelerythrin, Staurosporine, or Bisindoylemaleinide I blocked HDL and S1P induced phosphorylation of
Cx43. Data of 3–16 independent experiments were normalized to the phosphorylation state of Cx43 measured under control conditions. (B) Quanti-
fication of total Cx43 showed that the different treatments did not affect the total amount of Cx43. Data of 3–16 independent experiments were
normalized to the amount of Cx43 present under control conditions.
Connexin43 and HDL cardioprotective properties 45
GJIC might explain, at least partly, the earlier described anti-death
properties of HDL and S1P.
Given its effects on GJ dye permeability, the question arises
whether HDL also affects action potential propagation. Indeed, gap
junctional conductance (Gj) in cardiomyocytes has been shown to
be affected by treatment with TPA, a PKC activator.12 We have there-
fore evaluated impulse conduction velocities and maximal action
potential upstroke velocities in strands of neonatal rat ventricular car-
diomyocytes in response to HDL. We show that treatment with HDL
or S1P exerts very small though statistically significant effects on
impulse conduction velocity (decrease by 5%) and maximal
upstroke velocities (2.5%). At first glance, the combination of
reduced conduction velocities and reduced maximal upstroke vel-
ocities suggests that HDL slightly depolarized the preparations and,
accordingly, caused a reduction in sodium channel availability. We
have, however, observed similar parallel reductions in both conduc-
tion velocities and upstroke velocities during progressive gap junc-
tional uncoupling of cardiomyocytes strands with palmitoleic acid
before24 even though these findings contradict theory.25 Future
studies will have to show which of these mechanism(s) underlies
the effects of HDL and S1P on impulse conduction and action poten-
tial configuration.
In our in vitro studies, the observed effects of HDL and S1P on Cx43
phosphorylation were maximal after 5 min of incubation. HDL and
Figure 3 Cell-to-cell coupling in neonatal rat cardiomyocytes after treatment with HDL or S1P. (A) Immunofluorescent staining of phospho-Cx43
(Ser368) in neonatal rat ventricular cells under control condition or after 5 min HDL incubation. HDL induced an increase in the signal for phosphory-
lated Cx43 at the plasma membrane. Scale bar represent 50 mm. (B) GJIC was measured by microinjection of LY for 3 min. Images are representative
examples of dye diffusion in control cardiomyocyte clusters and after 5 min of HDL incubation. Asterisks indicate the microinjected cells. Scale bar
represent 50 mm. (C) LY diffusion is significantly decreased by HDL treatment; an effect that was blocked by PKC inhibition. S1P decreased LY diffu-
sion similar to HDL. Washouts led to total (HDL) or partial (S1P) restoration of dye diffusion. Activation of PKC by TPA induced a significant
reduction in dye coupling between cardiomyocytes. Results are presented as mean of 9–42 microinjections for each condition.
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S1P have been studied for cardioprotective properties against ischae-
mia and reperfusion in ex vivo settings, but the precise mechanism of
action remains unknown. Depending of the experimental conditions,
these compounds have been administrated at variable time points
before ischaemia or at the onset of reperfusion. Our ex vivo exper-
iments with isolated hearts show that 5 min of treatment with HDL
or S1P at the onset of reperfusion are able to reduce the cell death
induced by the 30 min ischaemia and reperfusion by 50%. In
studies performed with the ex vivo model of Langendorff perfusion,
HDL26 or synthetic HDL (sHDL)27 was infused 10 min before ischae-
mia or during the first 10 min of reperfusion, and induced in both
cases a significant improvement of myocardial function at reperfusion.
When sHDL was given at the time of reperfusion, myocardial function
was already significantly improved after 1 min of reperfusion,
Figure 4 Conduction and maximal upstroke velocities in neonatal rat cardiomyocytes after treatment with HDL or S1P. (A) Measurements of con-
duction velocities (left panel) and maximal action potential upstroke velocities (right panel) in strands of neonatal rat cardiomyocytes in the absence
(control) or presence of HDL. Three to eight minutes of HDL incubation led to a slight but significant reduction of both parameters that were com-
pletely restored upon washout. Results are presented as mean of 46–65 measurements for each condition. (B) Time-dependent changes in conduc-
tion velocities and maximal action potential upstroke velocities during HDL treatment when compared with controls (normalized values). HDL
induces a maximal decrease of 6.3% in conduction velocity and 2.3% of maximal upstroke velocity at 5 min of incubation. Results are presented
as mean of seven measurements for each condition. (C) Measurements of conduction velocities (left panel) and maximal potential action upstroke
velocities (right panel) in strands of neonatal rat cardiomyocytes in the absence (control) or presence of S1P. As for HDL treatment, the incubation
with S1P reduces slightly but significantly both parameters. Results are presented as mean of 57 measurements for each condition.
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illustrating the rapid action of sHDL.27 Moreover, in vivo anti-
arrhythmic effect of sHDL against ischaemia/reperfusion have been
demonstrated in rats where sHDL was given 10 min before the
onset of ischaemia.28 Finally, 2 min of S1P perfusion followed by
5 min of washout before ischaemia has been shown to significantly
improve of myocardial recovery at reperfusion and resulted in a sig-
nificant decrease in the infarct size.29 Altogether, our study shows
that short-term treatment with HDL or S1P at the onset of reperfu-
sion is sufficient to confer significant cardioprotection against ischae-
mia/reperfusion-induced cell death. In addition, our results link, for
the first time, Cx43 gap junction channels to the rapid effect of
HDL and S1P treatments in cardioprotection.
In conclusion, we show here that HDL and its constituent S1P
induce phosphorylation of Cx43 by a PKC-dependent mechanism.
This phosphorylation is associated with a 50% inhibition in the trans-
fer of large molecules between neonatal rat cardiomyocytes. In con-
trast, impulse propagation remains largely conserved. It therefore
appears that HDL, by increasing PKC activity, is ideally suited to coun-
teract spreading depression under pathological conditions: its actions
on cardiac GJs composed of Cx43 might limit spread of damaging
factors, while impulse conduction remains preserved.
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